View Single Post
Old 05-19-2005, 06:48 AM   #5
Christine MH
Guest
 
Posts: n/a
Hi Alaska Angel,

I suppose the reason is the risks involved. Most HER2+ women will have had anthracycline chemo, but the 52% reduction was found among women who had AC chemo followed by a taxol and even then there were concerns raised about the incidence of heart problems. Oncologists may worry that if they gave patients AC again they would do alot more harm than given patients herceptin by itself.
  Reply With Quote